We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences.
- Authors
Kalman, Jonathan M; Al-Kaisey, Ahmed M; Parameswaran, Ramanathan; Hawson, Joshua; Anderson, Robert D; Lim, Michael; Chieng, David; Joseph, Stephen A; McLellan, Alex; Morton, Joseph B; Sparks, Paul B; Lee, Geoffrey; Sanders, Prashanthan; Kistler, Peter M
- Abstract
Background Catheter ablation is an effective strategy in atrial fibrillation (AF). However, its timing in the course of management remains unclear. The aim of this study was to determine if an early vs. delayed AF ablation strategy is associated with differences in arrhythmia outcomes during 12-month follow-up. Methods and results One hundred patients with symptomatic AF referred to a tertiary centre for management were randomized in a 1:1 ratio to either an early ablation strategy (within 1 month of recruitment) or a delayed ablation strategy (optimized medical therapy followed by catheter ablation at 12 months post recruitment). The primary endpoint was atrial arrhythmia free survival at 12 months post-ablation. Secondary outcomes included: (i) AF burden, (ii) AF burden by AF phenotype, and (iii) antiarrhythmic drug (AAD) use at 12 months. Overall, 89 patients completed the study protocol (Early vs. Delayed: 48 vs. 41). Mean age was 59 ± 12.9 years (29% women). Pulmonary vein isolation was achieved in 100% of patients. At 12 months, 56.3% of patients in the early ablation group were free from recurrent arrhythmia, compared with 58.6% in the delayed ablation group (HR 1.12, 95% CI 0.59–2.13, P = 0.7). All secondary outcomes showed no significant difference including median AF burden (Early vs. Delayed: 0% [IQR 3.2] vs. 0% [5], P = 0.66), median AF burden amongst paroxysmal AF patients (0% [IQR 1.1] vs. 0% [4.5], P = 0.78), or persistent AF patients (0% [IQR 22.8] vs. 0% [5.6], P = 0.45) or AAD use (33% vs. 37%, P = 0.8). Conclusion Compared with an early ablation strategy, delaying AF ablation by 12 months for AAD management did not result in reduced ablation efficacy.
- Subjects
ATRIAL arrhythmias; CATHETER ablation; ATRIAL fibrillation; PULMONARY veins; MYOCARDIAL depressants
- Publication
European Heart Journal, 2023, Vol 44, Issue 27, p2447
- ISSN
0195-668X
- Publication type
Article
- DOI
10.1093/eurheartj/ehad247